G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells

Life Sciences

Volumn 60, Issue 2, 1996, Pages

  Ota, Takahide ^a   Maeda, Masayo ^a   Odashima, Shizuo ^a   Ninomiya Tsuji, Jun ^b   Tatsuka, Masaki ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cdk2; cell cycle; G1 arrest; ginsenoside Rh2; S phase arrest

Indexed keywords

GINSENOSIDE; GINSENOSIDE RH 2; UNCLASSIFIED DRUG; CDK2 PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; PROTEIN SERINE THREONINE KINASE; SAPONIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE PHASE; CONTROLLED STUDY; MOUSE; NONHUMAN; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL STRAIN 3T3; DRUG ANTAGONISM; DRUG EFFECT;

3T3 CELLS; ANIMALS; CDC2-CDC28 KINASES; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; G1 PHASE; GINSENOSIDES; MICE; MICE, INBRED BALB C; PROTEIN-SERINE-THREONINE KINASES; SAPONINS; TUMOR CELLS, CULTURED;

EID: 0030636535     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(96)00608-x     Document Type: Article

References (31)

1. 1. T. YOKOZAWA, H. SENO and H. OURA, Chem. Pharm. Bull. 23 3095-3100 (1975).
2. 2. H. OURA, S. HIAI, Y. ODAKA and T. YOKOZAWA, J. Biochem. 77 1057-1065 (1975).
3. 3. S. HIAI, H. YOKOYAMA, H. OURA and S. YANO, Endocrinol. Japon. 26 661-665 (1979).
4. 4. R. PUNNONEN and A. LUKOLA, Brit. Med. J. 281 1110-1111 (1980).
5. 5. P.T. PEARCE, I. ZOIS, K.N. WYNNE and J.W. FUNDER, Endoclinol. Japon. 29 567-573 (1982).
6. 6. H. YOSHIMURA, K. WATANABE and N. OGAWA, Eur. J. Pharmacol. 146 291-297 (1988).
7. 7. S. ODASHIMA, Y. NAKAYABU, N. HONJO, H. ABE and S. ARICHI, Eur. J. Cancer, 15 885-892 (1979).
8. 8. S. ODASHIMA, T. OTA, H. KOHNO, T. MATSUDA, I. KITAGAWA, H. ABE and S. ARICHI, Cancer Res. 45 2781-2784 (1985).
9. 9. T. OTA, K. FUJIKAWA-YAMAMOTO, Z.P. ZONG, M. YAMAZAKI, S. ODASHIMA, I. KITAGAWA, H. ABE and S. ARICHI, Cancer Res. 47 3863-3867 (1987).
10. 10. T. OTA, K. FUJIKAWA-YAMAMOTO, H. KOHNO and S. ODASHIMA, Korean J. Ginseng Sci. 14 238-243 (1990).
11. 11. K. FUJIKAWA-YAMAMOTO, T. OTA, S. ODASHIMA, H. ABE and S. ARICHI, Cancer J. 1349-352 (1987).
12. 12. T. TODE, Y. KIKUCHI, T. KITA, J. HIRATA, I. IMAIZUMI and I. NAGATA, J. Cancer Res. Clin. Oncol. 120 24-26 (1993).
13. 13. J.H. ZHU, T. TAKESHITA, I. KITAGAWA and K. MORIMOTO, Cancer Res. 55 1221-1223 (1995).
14. 14. S.-W. CHO, E.H. CHO and S.Y. CHOI, Life Sci. 57 1359-1365 (1995).
15. 15. C.J. SHERR, Cell 79 551-555 (1994).
16. 16. T. HUNTER and J. PINES, 79 573-582 (1994).
17. 17. T. KAKUNAGA and J.D. CROW, Science 209 505-507 (1980).
18. 18. I. KITAGAWA, M. YOSHIKAWA, M. YOSHIHARA, T. HAYASHI and T. TANIYAMA, Yakugaku Zasshi 103 612-622 (1983).
19. 19. E.G. BLIGH and W.Y. DYER, J. Biochem. Physiol. 37 911-917 (1959).
20. 20. T. OTA, M. MAEDA and S. ODASHIMA, J. Pharmaceut. Sci. 80 1141-1146 (1991).
21. 21. H. MATSUSHIME, D.E. QUELLE, S.A. SHURTLEFF, M. SHIBUYA, C.J. SHERR and J. KATO, Molec. Cell. Biol. 14 2066-2076 (1994).
22. 22. D.O. MORGAN, Nature 374 131-134 (1995).
23. 23. R.A. DEMEL and B. DE KRUYFF, Biochim. Biophys. Acta 457 109-132 (1976).
24. 24. P.L. YEAGLE, Biochim. Biophys. Acta 822 267-287 (1985).
25. 25. A. KOFF, A. GIORDANO, D. DESAI, K. YAMASHITA, J.W. HARPER, S. ELLEDGE, T. NISHIMOTO, D.O. MORGAN, B.R. FRANZA and J.M. ROBERTS, Science 257 1689-1694 (1992).
26. 26. L.-H. TSAI, E. HARLOW and M. MEYERSON, Nature 353 174-177 (1991).
27. 27. J. PINES and T. HUNTER, Nature 346 760-763 (1990).
28. 28. M. PAGANO, R. PEPPERKOK, F. VERDE, W. ANSORGE and G. DRAETTA, EMBO J. 11 961-971 (1992).
29. 29. F. GIRARD, U. STAUSFELD, A. FERNANDEZ and N.J.C. LAMB, Cell 67 1169-1179 (1991).
30. 30. F. ZINDY, E. LAMAS, X. CHENIVESSE, J. SOBCZAK, J. WANG, D. FESQUET, B. HENGLEIN and C. BRECHOT, Biochem. Biophys. Res. Commun. 182 1144-1154 (1992).
31. 31. Y. TERADA, M. TATSUKA, S. JINNO and H. OKAYAMA, Nature 376 358-362 (1995).